Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma ; volume:12 ; number:1 ; day:11 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
Scientific reports ; 12, Heft 1 (11.10.2022), 1-11, 12.2022
- Creator
-
Shimose, Shigeo
Hiraoka, Atsushi
Tanaka, Masatoshi
Iwamoto, Hideki
Tanaka, Takaaki
Noguchi, Kazunori
Aino, Hajime
Yamaguchi, Taizo
Itano, Satoshi
Suga, Hideya
Niizeki, Takashi
Moriyama, Etsuko
Shirono, Tomotake
Noda, Yu
Kamachi, Naoki
Okamura, Shusuke
Nakano, Masahito
Kawaguchi, Takumi
Kuromatsu, Ryoko
Koga, Hironori
Torimura, Takuji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-21528-2
- URN
-
urn:nbn:de:101:1-2022122821051054847486
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shimose, Shigeo
- Hiraoka, Atsushi
- Tanaka, Masatoshi
- Iwamoto, Hideki
- Tanaka, Takaaki
- Noguchi, Kazunori
- Aino, Hajime
- Yamaguchi, Taizo
- Itano, Satoshi
- Suga, Hideya
- Niizeki, Takashi
- Moriyama, Etsuko
- Shirono, Tomotake
- Noda, Yu
- Kamachi, Naoki
- Okamura, Shusuke
- Nakano, Masahito
- Kawaguchi, Takumi
- Kuromatsu, Ryoko
- Koga, Hironori
- Torimura, Takuji
- SpringerLink (Online service)
Other Objects (12)
Impact of Multi-Drug Sequential Therapy on Survival in Patients with Unresectable Hepatocellular Carcinoma
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
A stochastic process model for resistance deterioration of aging bridges
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
Correction to: Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Impact of Multi-Drug Sequential Therapy on Survival in Patients with Unresectable Hepatocellular Carcinoma
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
A stochastic process model for resistance deterioration of aging bridges
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
Correction to: Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Impact of Multi-Drug Sequential Therapy on Survival in Patients with Unresectable Hepatocellular Carcinoma
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
A stochastic process model for resistance deterioration of aging bridges
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib